ASTELIN Trademark

Trademark Overview

On Thursday, June 6, 2024, a trademark application was filed for ASTELIN with the United States Patent and Trademark Office. The USPTO has given the ASTELIN trademark a serial number of 98588595. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, September 17, 2025. This trademark is owned by Rising Pharma Holdings, Inc.. The ASTELIN trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines
astelin

General Information

Serial Number98588595
Word MarkASTELIN
Filing DateThursday, June 6, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, September 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements

Goods and ServicesAntihistamines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRising Pharma Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEast Brunswick, NJ 08816

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, December 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2024ASSIGNED TO EXAMINER
Wednesday, December 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 17, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, March 17, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 18, 2024NON-FINAL ACTION E-MAILED
Wednesday, December 18, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 18, 2025SUSPENSION LETTER WRITTEN
Tuesday, June 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 18, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, June 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 7, 2025ASSIGNED TO LIE
Saturday, August 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Related Keywords

astelin antihistamines